EMEA-001161-PIP02-11-M03 - paediatric investigation plan
Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox)
PIPHuman
Greek is available via eTranslation, the European Commission's machine translation service.
Translate to Greek | Important information about machine translation
Key facts
- Invented name
- Imvanex
- Active substance
- Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox)
- Therapeutic area
- Vaccines
- Decision number
- EMA/PE/0000223819
- PIP number
- EMEA-001161-PIP02-11-M03
- Pharmaceutical form(s)
- Suspension for injection
- Condition(s) / indication(s)
- Prevention of smallpox, monkeypox and related orthopoxvirus infection and disease
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date
- Compliance check done
- Όχι